PMID- 9435674 OWN - NLM STAT- MEDLINE DCOM- 19980209 LR - 20190510 IS - 0002-9513 (Print) IS - 0002-9513 (Linking) VI - 273 IP - 6 DP - 1997 Dec TI - Neurosteroid inhibition of cell death. PG - F869-76 LID - 10.1152/ajprenal.1997.273.6.F869 [doi] AB - Diverse gamma-aminobutyric acid (GABAA) receptor modulators exhibited novel cytoprotective effects and mechanisms of action in rabbit renal proximal tubules subjected to mitochondrial inhibition (antimycin A) or hypoxia. Cytoprotective potencies (50% effective concentration, EC50) were 0.3 nM allopregnanolone (AP) > 0.4 nM 17 alpha-OH-allopregnanolone (17 alpha-OH-AP) > 30 nM dehydroepiandrosterone sulfate (DHEAS) = 30 nM pregnenolone sulfate (PS) > 500 nM pregnenolone (PREG) > 30 microM muscimol > 10 mM GABA following antimycin A exposure. Maximal protection with AP and 17 alpha-OH-AP was 70%, whereas DHEAS, PS, PREG, and muscimol produced 100% cytoprotection. Experiments with AP, PS, and muscimol revealed the return of mitochondrial function and active Na+ transport following hypoxia/reoxygenation. Muscimol inhibited the antimycin A-induced influx of both extracellular Ca2+ and Cl- that occurs during the late phase of cell injury, whereas the neurosteroids only inhibited influx of Cl-. Radioligand binding studies with AP and PS did not reveal a specific binding site; however, structural requirements were observed for cytoprotective potency and efficacy. In conclusion, we suggest that the GABAA receptor modulators muscimol and neurosteroids are cytoprotective at different cellular sites in the late phase of cell injury; muscimol inhibits Ca2+ and subsequent Cl- influx, whereas the neurosteroids inhibit Cl- influx. FAU - Waters, S L AU - Waters SL AD - Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock 72205, USA. FAU - Miller, G W AU - Miller GW FAU - Aleo, M D AU - Aleo MD FAU - Schnellmann, R G AU - Schnellmann RG LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Physiol JT - The American journal of physiology JID - 0370511 RN - 0 (Alkaloids) RN - 0 (Benzylisoquinolines) RN - 0 (Isoxazoles) RN - 0 (Pregnanes) RN - 0 (Receptors, GABA-A) RN - 2763-96-4 (Muscimol) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - 57B09Q7FJR (Dehydroepiandrosterone Sulfate) RN - 642-15-9 (Antimycin A) RN - 8890V3217X (hydrastine) RN - EC 1.1.1.27 (L-Lactate Dehydrogenase) RN - K1M5RVL18S (gaboxadol) RN - SY7Q814VUP (Calcium) SB - IM MH - Alkaloids/pharmacology MH - Animals MH - Antimycin A/pharmacology MH - Benzylisoquinolines MH - Calcium/metabolism MH - Cell Death/drug effects MH - *Cell Hypoxia MH - Cells, Cultured MH - Dehydroepiandrosterone Sulfate/pharmacology MH - Female MH - Isoxazoles/pharmacology MH - Kidney Tubules, Proximal/*cytology/drug effects MH - Kinetics MH - L-Lactate Dehydrogenase MH - Mitochondria/drug effects/metabolism MH - Muscimol/chemistry/pharmacology MH - Oxygen Consumption/drug effects MH - Pregnanes/chemistry/*pharmacology MH - Rabbits MH - Receptors, GABA-A/drug effects/*physiology MH - gamma-Aminobutyric Acid/*pharmacology EDAT- 1998/01/22 00:00 MHDA- 1998/01/22 00:01 CRDT- 1998/01/22 00:00 PHST- 1998/01/22 00:00 [pubmed] PHST- 1998/01/22 00:01 [medline] PHST- 1998/01/22 00:00 [entrez] AID - 10.1152/ajprenal.1997.273.6.F869 [doi] PST - ppublish SO - Am J Physiol. 1997 Dec;273(6):F869-76. doi: 10.1152/ajprenal.1997.273.6.F869.